ArticlePostepy w kardiologii interwencyjnej = Advances in interventional cardiology2025
The predictive value of the triglyceride-glucose index for five-year all-cause mortality differs between patients with acute
Article in Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Aim: To investigate whether the predictive value of the triglyceride-glucose index (TyG) for 5-year all-cause mortality differs between patients with DNHF and those with ADCHF. Material and methods: 1160 patients out of 1740 hospitalized AHF patients were recruited and were classified into DNHF ( Results: DNHF patients had lower TyG levels than ADCHF patients ( Conclusions: Among non-diabetic patients, TyG index was significantly associated with 5-year all-cause mortality in ADCHF patients but not in DNHF patients. Differentiating the predictive value of TyG between DNHF and ADCHF patients could enhance our understanding and refine treatment strategies for individuals with AHF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.